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Aim: To investigate attention, memory, verbal-linguistic ability, and executive functions in symptom-free young offspring having a
parent with bipolar I disorder (BD1O) in comparison with healthy controls (CO).
Materials and methods: Thirty symptom-free BD1O and 37 CO were recruited. The groups (both all participants and those ≥11 years of
age) were well-matched for age, sex, IQ, and years of education. The neurocognitive battery included the Rey Auditory Verbal Learning
and Memory Test, Controlled Word Association Test, Digit Span Test, Trail Making Test, Auditory Consonant Trigram Test, Wisconsin
Card Sorting Test, Stroop Test, and Test of Variables of Attention.
Results: The BD1O group demonstrated impairments in psychomotor speed, focused attention, verbal attention, phonemic verbal
fluency, short-term memory, and learning functions and performed marginally worse in divided attention, information processing, and
working memory. No group difference was found in sustained attention, executive functions, or alternating attention.
Conclusion: Divided attention, information processing, and working memory seem to be important in evaluating the cognitive
pathology before the onset of affective psychopathology.
Key words: Bipolar I disorder, offspring, high-risk, neurocognitive functioning, endophenotype

1. Introduction
Bipolar disorder (BD) is a neurobiological disorder
with a multifactorial etiology, including oligogenic and
environmental influences (1). However, the identification
of vulnerability genes for this disorder is complicated by
the role of environmental factors, genetic heterogeneity,
and the variability of the observable phenotype (2).
This has prompted researchers to investigate the latent
but measurable trait markers more closely linked to
the responsible genes than the clinical phenotype itself,
which has been conceptualized as an endophenotype
(2,3). Endophenotypes are heritable biomarkers that
cannot be observed by the naked eye. Gottesman and
Gould’s definition of an endophenotype is that it should
be associated with illness, be heritable, and cosegregate
with a psychiatric illness within families, yet it should be
present even when the disease does not exist (i.e. stateindependent) and can be found in unaffected family
* Correspondence: erdemdeveci@gmail.com
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members at a higher rate than in the general population
(4).
Investigation of the abnormalities in neurocognitive
functioning has become the scope of interest within the
context of endophenotype approach (1). Individuals with
BD exhibit motor, perceptual, and cognitive disturbances
involving predominantly right hemisphere dysfunction
(5). These neurocognitive deficits are detectable during
the active phase of the disorder, regardless of the episode
type (6), in remission (7), and even in the first episode
(8,9), and they appear to worsen as the number of episodes
increases (10,11). This seems to be a cause for a continuous
impairment in social and occupational functioning (12)
in a large number of patients. The pursuit of identifying
strategies for early and preventive interventions motivated
researchers to look for these genetically transmitted
abnormalities in cognition and information processing
(13) in symptom-free first-degree relatives of patients
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having BD, which is conceptualized as a high-risk (HR)
approach. This approach refers to a method of studying
the etiology of a disorder by investigating individuals who
have an increased risk for developing it (14). Recently,
2 comprehensive reviews (1,15) were published that
included 23 studies investigating the neurocognitive
functions in unaffected HR relatives of patients with
BD. Of these studies, 18 targeted unaffected first-degree
relatives who were adults. These studies showed that they
performed worse than controls for memory (11,16), in
executive functions (11), in executive inhibitory processes
(17), and in psychomotor (attention) speed (18), as well as
for immediate verbal recall and visual episodic memory
(19).
In a large-scale extended pedigree study of cognitive
functioning in BD held in the central valley of Costa Rica,
709 Latino individuals between the ages of 15 and 77, of
which 660 were members of extended pedigrees with at
least 2 siblings diagnosed as having BD, were evaluated.
In that study, processing speed, working memory, and
declarative (facial) memory were found to be candidate
endophenotypes for BD (20).
However, studying unaffected HR relatives (parents,
twins, siblings, and offspring) at adult ages may be a
handicap for determining the cognitive endophenotypes,
since they have mainly passed through the peak period
of risk for BD with their vulnerability genes remaining
unexpressed (1). In this respect, evaluating the unaffected
but HR offspring of parents having BD during late childhood
as well as adolescence, who on average share 50% of genes
with their affected parent but are free of disease-associated
factors (e.g., medication side effects, chronicity, psychiatric
comorbidities, or potential neurotoxic effects of multiple
episodes on limbic structures), would provide a unique
opportunity to identify neurocognitive abnormalities
which exist prior to the typical onset of BD. The
remaining 5 reports (21–25) that were published in the 2
comprehensive reviews (1,15) were on young HR offspring
of parents having BD. The first 3 of these reports, which
used a limited number of tests, were published in the early
1980s when diagnostic practices according to the DSMIII were newly used to distinguish schizophrenia from BD,
thus making the reported diagnoses of the affected parents
doubtful. Only 2 of the studies conducted on young HR
offspring mentioned in the reviews were published in
the last decade. In the first study by McDonough-Ryan et
al., 28 offspring (10.2 ± 2.7 years old) of BD parents were
investigated with a limited neurocognitive battery, where
the major cognitive domains such as verbal memory,
attention, and executive functions were not evaluated (24).
In the second study, Klimes-Dougan et al. investigated 43
adolescent offspring (15.1 ± 2.5 years old) of BD mothers
from an affluent, high-achieving milieu, who were

compared with controls (25). The deficits that they found
were mainly in executive functions and attention.
The study conducted by Maziade et al. (26) was the first
to provide comparative information on developmental
trajectories of IQ and episodic memory impairments using
the same measures across early childhood, adolescence,
and young adulthood in offspring at genetic risk of major
psychoses. They found the offspring performance to be
lower than that of controls for IQ and episodic memory.
As discussed above, studies involving young HR
offspring of parents having BD appear to be sparse and
they have been conducted in different parts of the world;
this calls for investigation in other regions, as well, since
environmental factors have been suggested to affect the
gene expression and the pathogenesis of the disorder (27).
This prompted us to evaluate neurocognitive functioning
in symptom-free young offspring having a parent with
bipolar I disorder (BD1O) in eastern Turkey. We assessed
functioning in major cognitive domains such as attention,
memory, verbal-linguistic ability, and executive functions
using 8 well-validated neurocognitive tests that are
commonly used in current HR studies investigating
similar age groups.
2. Materials and methods
2.1. Subjects
We recruited 72 participants for evaluation at our
university psychiatry clinic. Of these, 3 of the control
offspring (CO) and 2 of the HR offspring who had a
parent with DSM-IV-TR bipolar I disorder (BD1O)
could not complete the neurocognitive assessment due
to illiteracy, inability to count, unwillingness to complete
the assessments, or physical complaints such as headache
and stomach ache. Thus, an analysis was carried out on
30 BD1O and 37 CO (Table 1). The diagnosis of bipolar
I disorder in parents was confirmed using the Turkish
version of the Structured Clinical Interview for DSMIV Axis I Disorders, Patient Edition (SCID-I). Children
having a lifetime diagnosis of substance use disorder,
attention deficit hyperactivity disorder, conduct disorder,
mood or psychotic disorder, mental retardation (IQ < 70),
serious head trauma, seizures, or any other organic mental
disorder were excluded. Healthy controls were chosen
from children of the parents who were referred to our
outpatient clinics other than neurology and psychiatry.
The parents of the healthy controls were evaluated
using the SCID-I nonpatient version in order to exclude
psychotic disorders and BD. Parents with any neurological
diseases or those having a family history (first-degree
relatives) of schizophrenia, BD, or schizoaffective disorder
were also excluded. The control group consisted of 37
healthy children (CO) matched for age, sex, IQ, and
years of education (Table 1). The exclusion criteria for
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the study group were also applied to the control group.
All subjects gave assent in conjunction with informed
consent provided by a parent. The study was approved
by the human research committee of our university. The
prior HR group that we reported on was a group of young
HR offspring having a parent with schizophrenia (28). To
maximize comparability of assessments across groups, we
used the same comprehensive neurocognitive battery and
matched the BD1O group for IQ as well as demographic
variables, such as age, sex, and years of education, with the
prior HR group.
Our intention in the present study was to evaluate young
HR offspring who had not reached the period of risk for
BD. For this reason, our study group consisted not only of
adolescents but also offspring in late childhood. The study
conducted by McDonough-Ryan et al. was a motivation
for us to combine adolescents and preadolescents, because
the age for their offspring at high risk for BD was 10.2 ±
2.7 years (24). Korkman et al. also evaluated 800 children
in terms of neurocognitive functioning and found that
neurocognitive development is rapid in the age range of 5
to 8 years and more moderate after age 9 (29). Therefore,
we will discuss the results of the participants ≥11 years
old, since it is suggested that age 11 is a threshold in the
maturation of neurocognitive performance (30,31).
2.2. Neurocognitive evaluation and IQ assessment
We used Kent E-G-Y Test and the Porteus Maze Test for
the assessment of IQ. The neurocognitive battery included
the Rey Auditory Verbal Learning Test (RAVLT), Auditory
Consonant Trigram Test (ACTT), Controlled Oral Word
Association Test (COWAT), Digit Span Test (DST), Trail
Making Test (TMT-A/B), Wisconsin Card Sorting Test
(WCST), Stroop Test, and Test of Variables of Attention
(TOVA) (32). The administration procedures for the
neurocognitive tests used in the present study are below.
2.3. Rey Auditory Verbal Learning and Memory Test
(RAVLT)
Verbal episodic memory was assessed with the RAVLT,
in which subjects had to learn a series of words presented
orally over 5 trials and were expected to immediately recall
them after each presentation (total recall of 5 trials) or with
a 20-min delay (delayed recall). They were also asked to
recognize target words between distracters (recognition).
The following measures were analyzed: total learning scores
(1–5 points), the total number of correctly recalled words
summed over the 5 learning trials; delayed recall, the
number of correctly recalled words after the 20-min delay;
true positives, the number of true answers that the subject
was expected to give in the recognition section of the test;
and recognition percent correct score, a measure calculated
by the formula (true positives + true negatives) / 50, as
proposed by Harris et al. (33).
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2.4. Auditory Consonant Trigram Test (ACTT)
This test measures divided attention, information
processing, and short-term memory. It is used for
measuring working memory. The total number of recalled
letters was used in evaluation.
2.5. Controlled Oral Word Association Test (COWAT)
This test is a measure of phonemic verbal fluency, in which
subjects had to produce the maximum number of words
with the given letters (K, A, and S, according to Turkish
standardization) within 1 min for each letter (34).
2.6. Digit Span Test (DST)
This test is a subunit of the Wechsler Intelligence Scale for
Children-III (35,36). It has 2 sections, digit span forward
and backward. The digit span forward section measures
verbal attention and the backward section measures verbal
working memory. In the forward section, the subject
repeats the numbers told to him/her by the rater, and in
the backward section the subject repeats the numbers
told to him/her backwards. The score is the sum of the
correctly recalled numbers in the forward and backward
sections and the total of both sections combined as well.
2.7. Trail Making Test (TMT-A/B)
This test assesses attention, mental flexibility, visual tracking,
and motor abilities (32). In part A, dots numbered between
1 and 25 are combined with a continuous line and in part
B, each letter is combined with a number alternatively. Part
A evaluates psychomotor (attention) speed and focused
attention whereas part B is the component that principally
measures executive functioning (37). In this study, the
times required to complete the 2 separate parts were taken
into account.
2.8. Wisconsin Card Sorting Test (WCST)
Executive functions such as cognitive flexibility, as well as
problem solving and abstraction abilities, were assessed
with the WCST-128 cards, in which participants had
to classify a series of cards into 3 categories after having
found the classification rule (color, number, or forms)
(38). In the present study, a computerized form of the test
(WCST: CV4) was used.
2.9. Stroop Test
As one of the main tools for evaluating executive
functioning, the Stroop Test assesses the ability to flexibly
direct attention in the presence of a distraction (i.e.
selective attention), inhibit a habitual behavioral pattern,
and display unusual behavior by taking into account the
individual’s speed of processing in measuring resistance to
interference (32).
2.10. Test of Variables of Attention (TOVA)
The TOVA is a computerized continuous performance test
used for assessing sustained attention. The subjects were
asked to push a button connected to a computer when they
recognized the target on the monitor for an uninterrupted
period of 20 min. The target is a small square appearing
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3.2. Neurocognitive assessment
As seen in Table 2, the BD1O group was significantly
impaired in divided attention, information processing,
and working memory (ACTT; P = 0.027) as well as
psychomotor (attention) speed and focused attention
(TMT-A; P = 0.034) compared to the CO. In addition,
short-term memory and learning functions were impaired
regardless of the recall ability (RAVLT: total learning
score, P = 0.009; delayed recalling score, P = 0.005;
recognition percent correct score, P = 0.020). There were
no significant differences between the BD1O and CO
groups in terms of sustained attention as assessed with the
TOVA; verbal attention as assessed with the DST forward;
executive functions and alternating attention (set shifting)
as assessed with the TMT-B, WCST, and Stroop Test; and
phonemic verbal fluency as assessed with the COWAT.
Table 2 shows that when an analysis was conducted
of participants ≥11 years old, the BD1O group showed
significant impairment in psychomotor (attention)
speed and focused attention (TMT-A; P = 0.006), and
short-term memory and learning functions regardless
of the recall ability (RAVLT: total learning score, P =
0.012; delayed recalling score, P = 0.008; true positives,
P = 0.039; recognition percent correct score; P = 0.004),
compared to the CO group. As for divided attention,
information processing, and working memory as assessed
with the ACTT, the BD1O group appeared to perform
marginally worse than the CO (P = 0.069). In addition,
the BD1O group also showed significant impairment in
verbal attention (DST forward score; P = 0.018) and in
phonemic verbal fluency (COWAT; P = 0.025). There were
no significant differences between the groups in terms
of sustained attention as assessed with the TOVA or in
executive functions and alternating attention as assessed
with the TMT-B, WCST, and Stroop Test. While there was
no difference in omission (P = 0.745) and commission (P

in the upper part of a rectangle. The nontarget is a
small square appearing in the bottom of the rectangle.
A stimulus flashed on the screen every 2 s. The target is
presented in 22.5% and 77.5% of the trials during the first
and second halves, respectively. Data were obtained in
the domains of omission error (inattention), commission
error (impulsivity), response time, and variability. All the
variables are recorded for each 5-min quarter and 10-min
half, as well as the overall total scores for each variable. The
scores are compared to the standardized norms, and the
interpretation of data is reported in a printable form (39).
2.11. Test environment
Cognitive assessment was conducted in the test laboratory
of our clinic. Optimal requirements for testing, such as
light, silence, and the physiological necessities of the
subjects, were fulfilled.
2.12. Statistical analyses
The statistics were performed with SPSS 11.0. The normality
distribution of test scores was tested by Kolmogorov–
Smirnov and Shapiro–Wilk tests where appropriate. The
relations between test scores were tested with the Mann–
Whitney U test and independent samples t-test. P-values
below 0.05 were accepted as significant.
3. Results
We performed 2 separate analyses of our data. The
first analysis included all the subjects. The second was
performed on participants who were ≥11 years old. The
results from the 2 analyses are shown together in Tables
1 and 2.
3.1. Sociodemographic features
The groups were well-matched for age, sex, IQ, and years
of education to prevent these variables from skewing the
outcome of the neurocognitive tests. The matching was not
lost when an analysis was conducted on participants ≥11
years old only (Table 1).

Table 1. Comparison of study group with healthy controls in age, sex, IQ, and years of education.
All subjects
Age

Subjects aged ≥ 11 years

BD1O (n = 30)

CO (n = 37)

Comparison (P)

BD1O (n = 21)

CO (n = 25)

Comparison (P)

12.32 ± 2.77

12.48 ± 2.58

0.81

13.73 ± 1.95

13.93 ± 1.65

0.70

Sex (%)

0.91

0.57

Female

15 (50%)

18 (48.6%)

11 (52.4%)

11 (44%)

Male

15 (50%)

19 (51.4%)

10 (47.6%)

14 (56%)

99.9 ± 16.5

106.05 ± 14.07

0.10

97.81 ± 12.19

103.24 ± 12.42

0.18

6.3 ± 2.8

6.0 ± 2.5

0.68

7.52 ± 1.96

7.44 ± 1.50

0.93

IQ
Education (years)

BD1O: High-risk offspring having a parent with bipolar I disorder. CO: Control offspring.
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Table 2. Comparison of study group with healthy controls according to cognitive tests.
All subjects

Subjects aged ≥ 11 years

BD1O

CO

Comparison

BD1O

CO

Comparison

(n = 30)

(n = 37)

(P)

(n = 21)

(n = 25)

(P)

Total learning scores (1–5)

49.93 ± 8.80

55.51 ± 6.73

0.009

50.19 ± 9.26

56.56 ± 6.70

0.012

Delayed recalling scores (7)

10.47 ± 3.09

12.41 ± 2.69

0.005

10.80 ± 2.65

12.92 ± 2.36

0.008

True positives

13.37 ± 2.77

14.11 ± 1.66

0.090

13.19 ± 3.09

14.16 ± 1.89

0.039

Recognition percent correct score

0.92 ± 0.14

0.97 ± 0.04

0.020

0.91 ± 0.17

0.98 ± 0.04

0.004

Auditory Consonant Trigram Test (ACTT)
total scores

38.47 ± 9.28

43.14 ± 7.63

0.027

40.14 ± 9.53

45.56 ± 7.64

0.069

Controlled Word Association Test (COWAT)
total scores

21.37 ± 8.25

25.54 ± 10.20

0.075

23.57 ± 7.44

28.76 ± 10.25

0.025

Forward section score

5.23 ± 1.96

6.05 ± 2.26

0.122

5.38 ± 1.80

6.88 ± 2.22

0.018

Backward section score

5.13 ± 2.14

5.08 ± 2.06

0.590

5.62 ± 2.16

5.68 ± 2.19

0.937

Total scores

10.37 ± 3.58

11.14 ± 3.98

0.639

11.00 ± 3.39

12.56 ± 3.99

0.195

Part A

52.71 ± 28.44

38.76 ± 15.83

0.034

46.49 ± 19.13

32.06 ± 11.25

0.006

Part B

166.44 ± 87.40

134.86 ± 81.98

0.113

150.71 ± 79.65

112.97 ± 63.95

0.140

37.51 ± 20.81

31.26 ± 11.67

0.377

34.26 ± 16.63

28.94 ± 11.16

0.349

4.00 ± 1.91

4.14 ± 2.14

0.576

4.24 ± 1.89

4.44 ± 2.06

0.586

Trials to complete first category

19.60 ± 21.84

20.45 ± 27.38

0.576

18.52 ± 18.55

19.44 ± 24.52

0.374

Total correct score

60.90 ± 16.52

61.88 ± 18.72

0.825

62.66 ± 17.37

65.84 ± 17.54

0.651

Total error score

39.10 ± 16.62

38.11 ± 18.73

0.870

37.33 ± 17.54

34.16 ± 17.54

0.691

Omission errors

10.17 ± 14.20

8.70 ± 17.68

0.780

7.19 ± 11.85

4.56 ± 5.02

0.745

Commission errors

35.77 ± 24.22

28.84 ± 17.93

0.267

31.52 ± 18.27

23.20 ± 13.07

0.120

Response time

374.18 ± 91.49

407.34 ± 90.57

0.152

334.48 ± 59.96

372.15 ± 60.77

0.041

Neurocognitive tests
Rey Verbal Learning and Memory Test

Digit Span Test (DST)

Trail Making Test (TMT)

Stroop Test main card reading time
Wisconsin Card Sorting Test (WCST)
Category score

TOVA test scores

BD1O: High-risk offspring having a parent with bipolar I disorder. CO: Control offspring.

= 0.120) scores between the groups, the BD1O group was
faster than the controls (TOVA response time; P = 0.041)
in giving responses to targets and nontargets.
4. Discussion
The BD1O group (≥11 years old) was found to be poor in
psychomotor (attention) speed, focused attention, verbal
attention, and phonemic verbal fluency as well as in short-
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term memory and learning functions, regardless of the
recall ability, in comparison with the control group. In
addition, the study group appeared to perform marginally
worse in divided attention, information processing, and
working memory. However, there were no significant
differences between the groups in terms of sustained
attention, executive functions, or alternating attention.
While there was no difference in omission and commission
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scores between the groups, the BD1O group was faster than
the controls in giving responses to targets and nontargets.
In a metaanalysis of neuropsychological functioning in
HR adult relatives, Bora et al. reported deficits in response
inhibition, alternating attention (set shifting), executive
function, verbal memory, and sustained attention (small to
medium effect sizes) (15). However, these deficits may be
components of the syndrome that are independent of the
affective disorder since they have passed through the age of
peak risk for BD. Therefore, studying young HR offspring
has some advantages in the sense that they are exempt from
the disease-associated factors seen in BD patients (1), and
that the risk for developing BD remains higher than for
the unaffected adult relatives, and so this would provide
an opportunity to identify the neurocognitive differences
present prior to the typical onset of the disorder (20). In a
study that was published after the comprehensive review (1)
mentioning the 5 studies investigating young offspring at
high risk for BD, Maziade et al. evaluated 23 offspring (17.45
± 4.54 years old) at extreme risk for BD due to a high family
genetic loading of the affected parents. After adjusting for
age, sex, and IQ, their HR offspring group showed poor
performance in verbal episodic memory, executive function/
problem solving, executive function/planning, letter
fluency, and visual episodic memory (40). In this study, the
reason why the impairments were found in a wide range
of domains could be the high family genetic loading of the
affected parents, since it is suggested that a dose-response
relation exists between the degree of family genetic loading
and cognitive impairments (41). Another reason could be
that the mean age for their HR group is relatively older
(17.45 years), which means that a subgroup of them might
have reached the age of incidence of BD and they could be
experiencing subsyndromal mood swings affecting the test
performance that might result in false positive findings.
In the current study, executive functioning was
measured using 3 well-validated tests: the WCST, Stroop,
and TMT-B. However, the study group showed no
impairment in any of these tests. Meyer et al. conducted a
longitudinal prospective study on a group of HR offspring
having a parent with BD, where diagnostic assessments
were carried out at 5 time points (42). In the follow-up
period, the impairment in executive functioning was
first detected during mid-adolescence (mean age: 14.84)
and the deficits in executive functioning and attention
preceded a BD diagnosis in 67% of young adults. KlimesDougan et al. also first detected impairment in executive
functioning and attention in their group at high risk for
BD during mid-adolescence (mean age: 15.1) (25). Deficits
in executive functioning are commonly reported in studies
investigating first-degree adult relatives at high risk for BD
(15). In our study, the reason for not detecting deficits
in executive functioning could be that the age group we

have studied was in the early adolescence stage (mean
age: 13.73). Since our results reflect a certain point in
time, the alterations that are suggested to appear in midadolescence cannot be ruled out. Giedd, by scanning the
adolescent brain through structural magnetic resonance
imaging, suggested that maturation of brain areas involved
in executive functioning occurs after adolescence (43).
Since the stabilization of neuromaturational processes
is suggested to be finalized after adolescence, this might
complicate the detection of probable deficits in cognitive
functioning during early stages of adolescence.
Another cognitive function widely studied within
the endophenocognitype concept is sustained attention
(vigilance), which can be defined as the ability to focus
on an activity long enough to complete a task. Studies
assessing sustained attention in unaffected first-degree
adult relatives of BD patients found no difference compared
to controls (44–46). However, 5 studies investigating
HR adolescent offspring of BD patients (21–25) found a
relatively wide pattern of deficits in sustained attention.
Overall, deficits in sustained attention appear to be present
only in HR offspring of BD patients, but not in older
relatives. We found no difference between the BD1O and
the CO groups in terms of sustained attention as assessed
with a computerized continuous performance test named
TOVA. A number of speculative possibilities may account
for the negative results (20). First, all of these assessments
are cross-sectional, which cannot exclude the impairments
that may appear in the future. Second, computers have
become a part of daily life and the young population is
especially highly exposed to visually based computer
games that reward reaction time and accurate visual
discrimination. This might have led them to compensate
for their slight attentional deficits when evaluated by
computerized tests. Third, it is suggested that attention
is one of the building blocks of IQ. Since we matched the
groups for IQ in our study, this could be another reason for
the nonsignificant differences between the groups.
Balanzá-Martinez et al. conducted a comprehensive
review discussing multiple cognitive domains (1). In terms
of psychomotor (attention) speed, 7 studies using the
TMT-A found no difference between unaffected relatives
and controls. As for phonemic verbal fluency, 5 out of 6
studies found no deficits between unaffected relatives
and controls (16,45,47–49). As for verbal learning and
memory, most of the studies found normal performances
on list learning tests (18,25,48,50). Kéri et al. found that
siblings of BD patients were impaired only in the delayed
recall measure, with spared recognition and immediate
recall. Only 2 twin studies showed a dysfunction in
measures of delayed recall as well as learning (45,46). Thus,
detection of deficits in our HR group in psychomotor
(attention) speed with the TMT-A; phonemic verbal

115

DEVECİ et al. / Turk J Med Sci

fluency with the COWAT; and verbal learning and
memory including immediate recall, delayed recall, and
recognition abilities with the RAVLT made a contribution
to this sparsely studied area. In addition, the BD1O group
appeared to perform marginally worse than the CO group
in divided attention as assessed with the ACTT. There are
a few studies that investigated this subdomain. Kremen et
al. did not find a dysfunction in divided attention, whereas
Sobczak et al. reported deficits in this subdomain in firstdegree BD relatives (44,47).
Another point worth considering is the matching
of groups for IQ to control this variable from skewing
the outcome of the neurocognitive tests. Since general
intelligence may affect the performance at each cognitive
test level (1), matching for IQ might have resulted in the
compensation of slight cognitive deficits. Thus, the group
differences might have been minimized.
In conclusion, our findings are parallel with the
reviews (51) suggesting that verbal memory/learning seem
to be more useful as a cognitive endophenotype for BD
as it meets all the established criteria (4). Comprehensive

evaluation of neurocognitive domains through the use of
sufficiently challenging tests to detect slight deficits may be
beneficial for determining endophenocognitypes for the
disorder and serve as a new target for early interventions.
Matching the groups for age, sex, and years of education
and assessing IQ and analyzing the data after adjusting for
these variables also appears to be important. In addition,
longitudinal studies with a larger sample size that match
endophenocognitype and genotype, as well as using
functional neuroimaging while administering cognitive
tests, would help in determining the pathophysiology of
the disorder. Brain development and its expression on
cognitive functioning continue throughout childhood
and adolescence. Since the age of 11 is suggested to
be a threshold in the maturation of neurocognitive
performance (30,31), stratifying the HR offspring and
controls as preadolescents and adolescents may be the first
step in the recruitment process. Furthermore, stratifying
the subjects as early, middle, and late adolescents may be
a practical approach in forming homogeneous groups in
terms of cognitive functioning.
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